The application of Fe3O4 nanoparticles in cancer research: A new strategy to inhibit drug resistance
✍ Scribed by Xuemei Wang; Renyun Zhang; Chunhui Wu; Yongyuan Dai; Min Song; Sebastian Gutmann; Feng Gao; Gang Lv; Jingyuan Li; Xiaomao Li; Zhiqun Guan; Degang Fu; Baoan Chen
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 536 KB
- Volume
- 80A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Although much effort has been extended to the efficient cancer therapies, the drug resistance is still a major obstacle in cancer chemotherapeutic treatments. Almost 90% of the cancer therapy failure is caused by the relative problems. Recently, the application of drug coated polymer nanospheres and nanoparticles to inhibit the related drug resistance has attracted much attention. In this report, we have explored a novel strategy to inhibit the multidrug resistance of the targeted tumor cells by combining the unique properties of tetraheptylammonium capped Fe~3~O~4~ magnetic nanoparticles with the drug accumulation of anticancer drug daunorubicin. Our results of confocal fluorescence and atomic force microscopy (AFM) as well as electrochemical studies demonstrate the remarkable synergistic effect of Fe~3~O~4~ nanoparticles on drug uptake of daunorubicin in leukemia K562 cells. These observations indicate that the interaction between the magnetic nanoparticles Fe~3~O~4~ and biologically active molecules on the membrane of leukemia cell lines may contribute to their beneficial effect on cellular uptake so that the synergistic enhanced effect of magnetic nanoparticles Fe~3~O~4~ on drug uptake of drug resistance leukemia K562 cells could be observed upon application of the Fe~3~O~4~ nanoparticles. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006